Perspectives E-mail Article
Printer Friendly
The US Healthcare Formula
Cost Control and True Innovation

November 25, 2011

Legislative and secular challenges are forcing a sea change in the US healthcare sector. Whether or not US healthcare reform is implemented as proposed, changes to the US healthcare system over the next three to five years will be sweeping—and the investment implications broad. We identify the stocks that are positioned for long-term gain.

The US Healthcare Formula Blue Paper

Morgan Stanley Blue Papers 



 Our Views
 Archives
Perspectives

 Search Our Views